- Home
- SNTG vs KLTO Comparison
SNTG vs KLTO Comparison
Compare SNTG & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- KLTO
- Stock Information
- Founded
- SNTG 2009
- KLTO 2019
- Country
- SNTG China
- KLTO United States
- Employees
- SNTG N/A
- KLTO N/A
- Industry
- SNTG Finance: Consumer Services
- KLTO
- Sector
- SNTG Finance
- KLTO
- Exchange
- SNTG Nasdaq
- KLTO NYSE
- Market Cap
- SNTG 5.2M
- KLTO 5.0M
- IPO Year
- SNTG 2021
- KLTO N/A
- Fundamental
- Price
- SNTG $1.68
- KLTO $0.16
- Analyst Decision
- SNTG
- KLTO
- Analyst Count
- SNTG 0
- KLTO 0
- Target Price
- SNTG N/A
- KLTO N/A
- AVG Volume (30 Days)
- SNTG 21.0K
- KLTO 152.3K
- Earning Date
- SNTG 05-06-2025
- KLTO 05-15-2025
- Dividend Yield
- SNTG N/A
- KLTO N/A
- EPS Growth
- SNTG N/A
- KLTO N/A
- EPS
- SNTG N/A
- KLTO N/A
- Revenue
- SNTG $146,472.00
- KLTO N/A
- Revenue This Year
- SNTG N/A
- KLTO N/A
- Revenue Next Year
- SNTG N/A
- KLTO N/A
- P/E Ratio
- SNTG N/A
- KLTO N/A
- Revenue Growth
- SNTG N/A
- KLTO N/A
- 52 Week Low
- SNTG $1.43
- KLTO $0.11
- 52 Week High
- SNTG $3.97
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- SNTG 48.37
- KLTO N/A
- Support Level
- SNTG $1.55
- KLTO N/A
- Resistance Level
- SNTG $1.77
- KLTO N/A
- Average True Range (ATR)
- SNTG 0.10
- KLTO 0.00
- MACD
- SNTG 0.01
- KLTO 0.00
- Stochastic Oscillator
- SNTG 73.91
- KLTO 0.00
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.